Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00EFO
|
||||
Former ID |
DIB000381
|
||||
Drug Name |
Interferon alpha-2b
|
||||
Synonyms |
IFN-alpha-XL; IFN-alpha (Medusa), Flamel; Interferon alpha-2b (subcutaneous/controlled release, Medusa); Interferon alpha-2b (subcutaneous/controlled release, Medusa), Flamel
|
||||
Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Phase 2 | [550975] | ||
Company |
Hanall biopharma; medtronic
|
||||
Target and Pathway | |||||
Target(s) | Interferon alpha 2 ligand | Target Info | Modulator | [550320] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Regulation of autophagy | |||||
PI3K-Akt signaling pathway | |||||
Toll-like receptor signaling pathway | |||||
RIG-I-like receptor signaling pathway | |||||
Cytosolic DNA-sensing pathway | |||||
Jak-STAT signaling pathway | |||||
Natural killer cell mediated cytotoxicity | |||||
Tuberculosis | |||||
Hepatitis C | |||||
Hepatitis B | |||||
Measles | |||||
Influenza A | |||||
Herpes simplex infection | |||||
Autoimmune thyroid disease | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Downstream signaling in naï | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.